Table IV.
Comparison | No. of pairs |
Endpoint in treatment |
Endpoint in control |
PSM | LR | ||
---|---|---|---|---|---|---|---|
OR (CI) | p | OR (CI) | p | ||||
Ventilation | |||||||
90-day exposure window | 12,504 | 936 (7.5%) | 1,118 (8.9%) | 0.82 (0.75-0.90) | <0.001 | 0.79 (0.74-0.85) | <0.001 |
360-day
exposure window |
20,690 | 1,524 (7.4%) | 1,701 (8.2%) | 0.89 (0.83-0.95) | 0.001 | 0.79 (0.74-0.83) | <0.001 |
Mortality | |||||||
90-day exposure window | 12,504 | 390 (3.1%) | 479 (3.8%) | 0.81 (0.70-0.93) | 0.002 | 0.83 (0.75-0.92) | <0.001 |
360-day
exposure window |
20,690 | 671 (3.2%) | 783 (3.8%) | 0.85 (0.76-0.94) | 0.003 | 0.87 (0.80-0.94) | <0.001 |